Canada is an established leader in the life sciences, with a business landscape that’s promising but unique. Let’s take a look at the Canadian life sciences landscape, the benefits of doing business here, and key points that international companies should be aware of to ensure success.
Read MoreThe CNS sector presents a variety of opportunities for pharmaceutical companies of all sizes and stages given the complexity and prevalence of neurological disorders. Here are some key areas of opportunity, which you may find relevant as you consider your own pipeline.
Read MoreWhat does the future hold for the life science sector as we head into 2024?
Like years past, there was a continued blending of digital technologies with scientific advancement. A recent Deloitte report boiled it down to three key trends: digital transformation, generative AI, and adoption of digital health tools. In this post we explore each, as well as additional trends expected to share healthcare and life science innovation in the year to come.
Read More
